Weight loss drug’s heart benefits extend to people with heart failure, study finds

The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have cardiovascular disease, whether or not they also have heart failure, according to a new study led by UCL’s Professor John Deanfield.

Facebook Comments